We start the day's other headlines with the latest elections taking place in Mississippi and Georgia.

For the Democrats, a hotly contested primary race features Congressman Benny Thompson, who's fighting off a challenge from newcomer Evan Turnage.

The 78-year-old Thompson is widely expected to prevail against the 34-year-old turnage, who's taken jabs at Thompson's age.

Meantime, in Georgia, it's a crowded field in a special election to replace former

Congresswoman Marjorie Taylor Green.

Trump-backed Clay Fuller is considered the frontrunner among Republicans in the deeply

conservative district, though Democrat Sean Harris is expected to put in a strong showing in a race

that political analysts say is largely defined by the economy.

Virtually everywhere, and including this district, it's the pocketbook issues. It's affordability, it's prices, it's inflation.

It's those things that everybody has to deal with on a daily basis. And so I think this is a real economics kind of election.

We'll see if the foreign policy issues or immigration cuts into that at all.

With 17 candidates in the race, it's unlikely anyone will top the 50 percent threshold

to prevent a runoff next month.

Today's vote comes as Democrats sued the Trump administration over whether it plans to send armed federal agents to election sites this year.

The Democratic National Committee alleges that three federal agencies failed to respond to nearly a dozen Freedom of Information Act requests on the subject.

The DNC says the requests must be fulfilled to, quote, ensure that the American people obtain

timely knowledge of potential threats to free and fair elections. President Trump has not

discussed formal plans to deploy the military or federal agents to polling places this fall,

but voting rights groups have raised concerns following the president's comments to, as he put it, nationalize

elections and after FBI agents raided an election warehouse in Georgia early this year.

The FDA today approved a drug for a rare genetic disorder, but not for autism, as some officials

had previously suggested. Back in September, top health officials in the Trump administration

...